Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 13, 2026, 9:30 AM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $127 as of April 14, 2026. Its market cap has decreased by -99.00% in one year.
Market Cap
127.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 127.00, a decrease of -100.00%. That is a compound annual growth rate of -97.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 127.00 | -99.67% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| America Great Health | 21.15K |
| Health Sciences Group | 20.51K |
| Trevena | 19.18K |
| Scopus BioPharma | 16.83K |
| NanoLogix | 16.29K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| Biostax | 10.71K |